A61K 45/00
Medicinal preparations containing active ingredients not provided for in groups a61k31/00 -
Official title: Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
A61K45/00 (Medicinal preparations containing active ingredients not provided for in groups a61k31/00 -) appears on 41,233 US grants and 80,626 published applications in this corpus.
Search patents in A61K- Granted patents
- 41,233
- Published applications
- 80,626
- Assignees
- 17,029
- Inventors
- 102,248
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 4 | 0 |
| 1978 | 4 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 10 | 0 |
| 1983 | 3 | 0 |
| 1984 | 14 | 0 |
| 1985 | 8 | 0 |
| 1986 | 9 | 0 |
| 1987 | 11 | 0 |
| 1988 | 20 | 0 |
| 1989 | 26 | 0 |
| 1990 | 19 | 0 |
| 1991 | 21 | 0 |
| 1992 | 15 | 0 |
| 1993 | 37 | 0 |
| 1994 | 46 | 0 |
| 1995 | 64 | 0 |
| 1996 | 130 | 0 |
| 1997 | 233 | 0 |
| 1998 | 249 | 0 |
| 1999 | 271 | 0 |
| 2000 | 305 | 0 |
| 2001 | 430 | 207 |
| 2002 | 488 | 853 |
| 2003 | 484 | 1249 |
| 2004 | 324 | 1508 |
| 2005 | 337 | 1624 |
| 2006 | 395 | 1504 |
| 2007 | 350 | 1522 |
| 2008 | 333 | 1603 |
| 2009 | 418 | 1848 |
| 2010 | 680 | 2297 |
| 2011 | 712 | 2365 |
| 2012 | 1056 | 2406 |
| 2013 | 1630 | 3633 |
| 2014 | 2123 | 4573 |
| 2015 | 2453 | 4490 |
| 2016 | 2719 | 4696 |
| 2017 | 2976 | 4578 |
| 2018 | 2835 | 4349 |
| 2019 | 2838 | 4441 |
| 2020 | 2823 | 5048 |
| 2021 | 2609 | 5181 |
| 2022 | 2572 | 4913 |
| 2023 | 2195 | 4831 |
| 2024 | 2235 | 4563 |
| 2025 | 2312 | 3796 |
| 2026 | 1400 | 2548 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Hydrogels as oral delivery dosage forms, methods of making and using same6 Oct 2026US 12,751,917 B2VeraMorph LLC
- Parenteral treatments involving aminoadamantane derivatives6 Oct 2026US 12,751,934 B2Shinkei Therapeutics, Inc.
- Dosage forms for TYK2 inhibitors6 Oct 2026US 12,751,948 B2Bristol-Myers Squibb Company
- CDK inhibitors6 Oct 2026US 12,751,951 B2Genentech, Inc.
- Anti-Claudin18.2 antigen-binding fragment or antibody, and use thereof182551196 Oct 2026US 12,751,972 B2Guangzhou Bio-Gene Technology Co., Ltd
- Tea compositions comprising paraxanthine and methods of production thereof8 Oct 2026US 2026/0305643 A1
- Interface structure for a bioelectrode8 Oct 2026US 2026/0306000 A1Teknologian tutkimuskeskus VTT Oy
- Aqueous formulations comprising fullerene, structured water, dissolved hydrogen gas, minerals and additives8 Oct 2026US 2026/0306402 A1Best Planet Science LLC
- Liposome compositions and medical uses thereof8 Oct 2026US 2026/0306404 A1
- Sulfurized imidazoles in ophthalmic formulations8 Oct 2026US 2026/0306431 A1Geneiii Biotech Company Ltd.
Most cited
By later US patents
- Retrograde tissue splitter and method1,605US 5,449,355 AValleylab, Inc. · 1995
- Retrograde tissue splitter and method1,585US 5,797,906 AValleylab, Inc. · 1998
- Method of treating androgen independent prostate cancer1,091US 9,040,574 B2Natrogen Therapeutics International, Inc. · 2015
- Anti-angiogenic compositions and methods of use968US 5,716,981 AAngiogenesis Technologies, Inc. · 1998
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015